NSF Magnet Lab

In Jeffrey Mervis's story "Huge NSF Magnet Grant Will Test FSU's Mettle" [The Scientist, Oct. 1, 1990, page 3], little or no coverage is given to the majority views of the three committees of users and related scientists whose decisions went against the Florida State University grant and in favor of the original site. In particular, the story is almost devoid of comment on what should have been the primary consideration, which is: Which proposal will be best for science and technology in the Un

Written byPhilip Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

* Interrupt the highest magnetic field user research in this country for four to five years, just at a time when several very important scientific and technical problems need to be solved--that is, high Tc superconductor studies under high fields. It is proposed that users go to France or Japan!

* Purchase foreign-made magnets in preference to developing our own technology.

* Distance the laboratory from the community of first-rate research students. No new facilities will make Florida State's Tallahassee campus into a magnet for the top 10 percent of students, such as one has at Massachusetts Institute of Technology and the Boston area generally. Many first-rate students were trained in the MIT magnet lab. The story might also have pointed out that the members of the National Science Board are not working scientists; the quotes from them reflect nothing like a scientist's concern for quality above all.

Many of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies